- Home
- HWBK vs CDXS Comparison
HWBK vs CDXS Comparison
Compare HWBK & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HWBK
- CDXS
- Stock Information
- Founded
- HWBK 1865
- CDXS 2002
- Country
- HWBK United States
- CDXS United States
- Employees
- HWBK N/A
- CDXS N/A
- Industry
- HWBK Major Banks
- CDXS Major Chemicals
- Sector
- HWBK Finance
- CDXS Industrials
- Exchange
- HWBK Nasdaq
- CDXS Nasdaq
- Market Cap
- HWBK 242.4M
- CDXS 230.3M
- IPO Year
- HWBK N/A
- CDXS 2010
- Fundamental
- Price
- HWBK $27.90
- CDXS $2.81
- Analyst Decision
- HWBK
- CDXS Buy
- Analyst Count
- HWBK 0
- CDXS 2
- Target Price
- HWBK N/A
- CDXS $11.00
- AVG Volume (30 Days)
- HWBK 13.4K
- CDXS 1.1M
- Earning Date
- HWBK 04-23-2025
- CDXS 05-01-2025
- Dividend Yield
- HWBK 2.76%
- CDXS N/A
- EPS Growth
- HWBK 1820.23
- CDXS N/A
- EPS
- HWBK 2.61
- CDXS N/A
- Revenue
- HWBK $71,882,000.00
- CDXS $59,345,000.00
- Revenue This Year
- HWBK N/A
- CDXS $14.56
- Revenue Next Year
- HWBK N/A
- CDXS $21.41
- P/E Ratio
- HWBK $10.60
- CDXS N/A
- Revenue Growth
- HWBK 36.16
- CDXS N/A
- 52 Week Low
- HWBK $17.86
- CDXS $2.43
- 52 Week High
- HWBK $35.95
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- HWBK 41.31
- CDXS 42.35
- Support Level
- HWBK $27.17
- CDXS $2.43
- Resistance Level
- HWBK $28.02
- CDXS $3.04
- Average True Range (ATR)
- HWBK 1.05
- CDXS 0.22
- MACD
- HWBK 0.07
- CDXS 0.08
- Stochastic Oscillator
- HWBK 62.12
- CDXS 51.35
About HWBK Hawthorn Bancshares Inc.
Hawthorn Bancshares Inc is a financial holding company and along with its subsidiary, it conducts general banking and trust business, offering its customers checking and savings accounts, internet banking, certificates of deposit, trust services, brokerage services, and safety deposit boxes. The company also offers a range of lending services, including commercial and industrial loans, single payment personal loans, installment loans, and commercial and residential real estate loans.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.